Clinical uses of polyene macrolides
Patent 5880101 Issued on March 9, 1999. Estimated Expiration Date: 
February 27, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
February 27, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesMethod for treating inflammation Patent #: 4289757 InventorAssigneeApplicationNo. 765616 filed on 02/27/1997US Classes:514/29, The hetero ring has exactly 13 ring carbons (e.g., erythromycin, etc.)514/31, The hetero ring has 20 or more ring carbons (e.g., nystatin, etc.)514/824, ARTERIOSCLEROSIS514/825, ARTHRITIS514/838, CIRRHOSIS514/851, CYSTIC FIBROSIS514/859, Acne514/861, Eczema514/863, Psoriasis514/866, DIABETES514/877, GALLSTONE514/894, Hepatitis514/899, MENSTRUAL DISORDER514/903, MULTIPLE SCLEROSIS514/930, VASOCONSTRICTOR (NONDECONGESTANT)514/931VENERAL DISEASEExaminersPrimary: Weddington, Kevin E.Attorney, Agent or FirmInternational ClassA61K 031/70Foreign Application Priority Data1994-06-28 GBAbstractThe present invention relates to the use of at least one polyene macrolide for the preparation of pharmaceutical compositions for the treatment of diseases that are associated with an impaired energy turnover. Particularly, the present inventions allows to specifically stimulate the energy conversion in human cell, i.e. to stimulate the cell metabolism, and thus to treat or prevent a series of diseases.Field of SearchThe hetero ring has exactly 13 ring carbons (e.g., erythromycin, etc.)The hetero ring has 20 or more ring carbons (e.g., nystatin, etc.) ARTERIOSCLEROSIS ARTHRITIS CIRRHOSIS Eczema Psoriasis DIABETES CYSTIC FIBROSIS Acne GALLSTONE Hepatitis MENSTRUAL DISORDER MULTIPLE SCLEROSIS VASOCONSTRICTOR (NONDECONGESTANT) VENERAL DISEASE | |
